Abstract. We previously reported that serofendic acid, a lipophilic extract of fetal calf serum, protects against oxidative stress in primary culture of neonatal rat cardiomyocytes. However, the effect of serofendic acid on myocardial ischemia-reperfusion injury in vivo is yet to be determined. In the present study, we investigated the effect of intravenous administration of serofendic acid on ischemia-reperfusion injury induced by transient occlusion of the left coronary artery in rats. The rat heart was subjected to 25min ischemia followed by 2h reperfusion. Bolus intravenous administration of serofendic acid (1 -10 mg/kg) given twice reduced the infarct volume in a dose dependent manner. The protective effect of serofendic acid was abolished by pretreatment with 5hydroxydecanoate, a blocker of mitochondrial ATPsensitive potassium channels. For further testing of the protective effect of serofendic acid at the subcellular level, we monitored mitochon drial membrane potential (MMP) in individual cells using realtime twophoton imaging of Langendorffperfused rat heart. A 25min noflow ischemia, followed by reperfusion caused progressive MMP loss. Serofendic acid significantly reduced the number of cells undergoing MMP loss. These results suggest that serofendic acid protected cardiac myocytes against myocardial ischemia-reperfusion injury by preserving the functional integrity of mitochondria.
Introduction
Ischemic heart disease is the leading cause of morbidity and mortality in all industrialized countries. After acute myocardial ischemia, myocardial reperfusion by throm bolysis, percutaneous coronary intervention or cardiac surgery is the effective treatment for reducing infarct size and improving clinical outcome. However, it is well known that reperfusion can also induce injury called "reperfusion injury" (1 -3) .
Mitochondria play a critical role in cell death in response to a variety of stresses such as myocardial ischemia-reper fusion (4 -6) . Opening of the mitochondrial permeability transition pore (MPTP), which is a nonselective large conductance channel, is a major mechanism of cell death by myocardial ischemia-reperfusion. MPTP opening results in the loss of mitochondrial membrane potential (DYm), matrix swelling, and the release of cytochrome c and other proapoptotic factors that lead to cell death (7 -9) . Mito chondrial matrix calcium ([Ca 2+ ]m) overload and increased reactive oxygen species (ROS) favor MPTP opening (10) . ]m overload and ROS generation should be an effective strategy for the protection of hearts against I/R injury.
Serofendic Acid Protects Against Myocardial Ischemia-Reperfusion Injury in Rats
We have shown that ATPsensitive potassium channels located in the inner mitochondrial membrane (mitoKATP channels) play a central role in the signaling cascade of protection against oxidative stress in cardiac ventricular myocytes (11, 12) and cerebellar granule neurons (13, 14) . Opening of mitoKATP channels prevent [Ca 2+ ]m overload and ROS generation, thereby inhibiting the MPTP opening in both types of cells (13, 15 -17) . Diazoxide, a selective opener of mitoKATP channels, has been shown to have protective effects against myocardial ischemia-reperfusion both in vitro (18, 19) and in vivo (20, 21) . Unfortunately, the clinical use of this agent has been hampered by unwanted side effects such as excessive hypotension and edema.
We previously found a neuroprotective substance, sero fendic acid, in a lipophilic extract of fetal calf serum. Serofendic acid is a 15hydroxy17methylsulfinylatisan19 oic acid, a sulfurcontaining atisantype diterpenoid (22) . It is a lowmolecularweight (MW 382) compound and exhibits a potent protective effect against neurotoxicity induced by glutamate, NO, and oxidative stress without inhibiting glutamate receptors in cultured cortical, striatal, and spinal cord neurons (23 -26) . Moreover, in cardiac myocytes, serofendic acid was found to suppress cell death induced by oxidative stress (27, 28) . The mechanism of protection remains unclear, but we have demonstrated that serofendic acid preserves mitochondrial functional integrity and inhibits the generation of hydroxyl radical and caspase3 activation (23, 24, 26, 27) .
In the present study, we investigated whether serofendic acid exerts protective effects against myocardial ischemiareperfusion injury in vivo, using a rat model of transient left coronary artery occlusion.
Materials and Methods

Animals
Experiments were carried out using 10weekold male SpragueDawley rats weighing 300 -330 g, which were purchased from Nihon SLC (Shizuoka). The animals were treated in accordance with the guidelines of Kyoto Univer sity Animal Experimentation Committee, and the guidelines of The Japanese Pharmacological Society.
Surgical procedure of left coronary artery occlusion and drug administration
Surgical preparation was essentially the same as described in detail previously (29) . Briefly, rats were anes thetized with pentobarbital sodium (40 mg/kg, i.p.). Oxygen was supplemented for ventilation to maintain arterial blood gases within the physiological range. Rectal tempera ture in each rat was maintained within 37°C -38°C using a heating pad. The heart was exposed via left thoracotomy, and a coronary snare was placed around the left coronary artery by using a 50 silk thread. Heparinized salinefilled catheters were placed in the femoral vein and the carotid artery for drug infusion and monitoring arterial blood pres sure using a DX100 pressure transducer (NihonKohden, Tokyo). After a 20min stabilization period following surgery, rats were administered intravenously vehicle, serofendic acid, or diazoxide. Fifteen minutes after treat ment, the left coronary artery was occluded for 25 min and then reperfused. Five minutes before reperfusion, vehicle, serofendic acid, or diazoxide was administered intravenously. After 2 h of reperfusion, the heart was excised and mounted onto a Langendorff apparatus. The heart was perfused with Tyrode's solution containing 134 mM NaCl, 4 mM KCl, 1.2 mM MgSO4, 1.2 mM NaH2PO4, 10 mM HEPES, 11 mM dglucose, and 2 mM CaCl2 (pH = 7.4, adjusted with 1 M NaOH) to wash out the blood, and then the coronary artery was reoccluded. A saline suspension of fluorescent polymer microspheres (Duke Scientific, Palo Alto, CA, USA) was infused into the aorta to mark the area at risk negatively, and the heart was frozen at −20°C. Frozen hearts were sliced into 2mm sections and stained with triphenyltetra zolium chloride (TTC). Area of infarct and area at risk were determined using image analysis software (Image J).
Two-photon laser-scanning microscopy imaging of Langendorff-perfused rat hearts
Surgical preparation was essentially the same as de scribed in detail previously (30) . Rats were anesthetized with pentobarbital sodium (40 mg/kg, i.p.) and the heart was excised. The ascending aorta was cannulated with a customized needle and hearts were perfused in the Langendorff mode. Perfusion was carried out at a constant mean perfusion pressure with oxygenated (95% O2) Tyrode's solution. After an initial perfusion period of approximately 10 min, the buffer was switched to oxygenated Tyrode's solution containing 100 nM tetramethyl rhodamine ethyl ester (TMRE) and this was followed by a 10min washout with dyefree solution. The temperature was maintained at 37°C using a solution heater and a platform heater (Warner Instruments, Hamden, CT, USA) installed on the microscope stage. After dye loading and washout periods, the hearts were placed in a circular glassbottomed dish (35mm diameter) and subjected to myocardial ischemia-reperfusion (25 min of global ischemia followed by 60 min of reperfusion). Ischemia was achieved by clamping the perfusion line and reperfu sion by releasing the clamp. During the reperfusion period, the hearts were perfused with Tyrode's solution containing 10 mmol/L 2,3butanedione monoxime to eliminate con tractioninduced movement of the heart during image acquisition. Images were recorded with a Zeiss LSM510 laser scanning microscope modified for TPLSM. Illumina tion for twophoton excitation was provided by a mode locked Ti:Sapphire laser (SpectraPhysics, Irvine, CA, USA); the excitation wavelength was 810 nm. Hearts were imaged through a Zeiss 40 × 1.30 numerical aperture oilimmersion objective with a working distance of 200 mm. Emitted light was collected by two photomultiplier tubes fitted with bandpass filters for 565 -615 nm (for TMRE). The images shown are representative of at least three indepen dent experiments, and we confirmed the reproducibility of the responses. Postacquisition image analysis was performed using software (Image J). From the image sequences, regions of interest were drawn over a part of an individual cell, and fluorescence signals within these regions were collected over time. DYm was monitored using mean TMRE brightness within the regions.
Statistics
Data are expressed as means ± S.E.M. Statistical analyses were performed using GraphPad Instat (Graph Pad Soft ware, San Diego, CA, USA). The effects on the infarct volume and DYm were analyzed using oneway analysis of variance followed by Tukey's test. The effect of serofendic acid on the infarct volume in a dosedependent manner was analyzed with Dunnett's twotailed test. Twoway analysis was used for mean blood pressure. Statistical significance was defined as a probability value of less than 5%.
Results
Dose-dependent protective effect of serofendic acid against myocardial ischemia-reperfusion
We examined the protective effect of serofendic acid on infarct size induced by myocardial ischemia-reperfusion by TTC staining. Bolus intravenous administration of serofendic acid was given twice: 15 min before ischemia and 5 min before reperfusion. Figure 1A shows representa tive images of perfused fluorescent polymer microspheres and TTC staining. The area that was not perfused with fluorescent polymer microspheres indicated the ischemic area (area at risk) during left coronary artery occlusion. There was no difference in the size of the area at risk between vehicle and serofendic acid-treated groups (Fig. 1B) . The infarct area indicated by negative staining by TTC was smaller in the serofendic acid (10 mg/kg)treated group than in the vehicletreated group. The protective effect of serofendic acid was dosedependent in the range of 1 -10 mg/kg (Fig. 1C) . Myocardial sections in the vehicle treated group were more likely to have intramyocardial bleeding (brownish area inside the infarct zone), indicating greater myocardial damage (arrows in lower panels in Fig. 1A) . 
Involvement of mitochondrial ATP-sensitive potassium channels in myocardial protection of serofendic acid
We next investigated the mechanism by which serofendic acid protects against myocardial ischemia-reperfusion. We previously suggested the involvement of activation of mitoKATP channels in the protective effect of serofendic acid against H2O2 injury in neonatal rat cardiomyocytes (27) . Therefore, we examined whether 5hydroxydecanoate (5HD), a mitoKATPchannel blocker, affects the protective effect of serofendic acid in the in vivo model (Fig. 2) . We administered 5HD 5 min before the administration of serofendic acid. It abolished the protective effects of serofendic acid, whereas 5HD alone did not affect the infarct size. Moreover, the effect of serofendic acid on infarct size reduction was comparable to that of diazoxide, a wellknown mitoKATPchannel opener. These results suggest that myocardial protection of serofendic acid is mediated by opening mitoKATP channels.
Effects of serofendic acid on mean blood pressure
Previous reports showed that diazoxide exhibits side effects: reduction of blood pressure or increase of blood glucose, because of the action on the plasma membrane ATPsensitive potassium channels (31, 32) . We measured the rate of reduction of mean blood pressure at 15 min after first administration to clarify whether serofendic acid affects blood pressure (Fig. 3) . Blood pressure dropped to about 90% after the administration of diazoxide. Unlike diazoxide, serofendic acid did not change the blood pres sure. Moreover, treatment with serofendic acid did not affect the blood glucose level (data not shown). These results indicate that serofendic acid may have fewer side effects than diazoxide.
Effect of serofendic acid on mitochondrial membrane potential loss induced by ischemia-reperfusion
The opening of mitoKATP channels leads to the prevention of DYm loss induced by several stresses (33) . For further testing of the protective effect of serofendic acid at the subcellular level, we monitored DYm in individual cells using realtime twophoton imaging. Timelapse confocal analysis of Langendorffperfused rat heart was performed at 5min intervals. At first, we confirmed that TMRE fluorescence did not change during the 85 min of observa tion in the sham group (Fig. 4A, sham) . In contrast, noflow ischemia followed by reperfusion caused progressive loss of the red fluorescence intensity, indicating DYm loss (Fig. 4A, vehicle) . Pretreatment of serofendic acid remark ably prevented the DYm loss (Fig. 4A, serofendic acid) . Remarkably, none of the cells in the serofendic acid group lost DYm during the ischemic period. Moreover, serofendic acid robustly delayed the onset of DYm loss during the reperfusion period. Ten cells were randomly selected in each group, and the TMRE fluorescence intensity from each individual cell was plotted, as shown in Fig. 4B . Serofendic acid decreased the number of cells undergoing the dissipa tion of DYm. Figure 4C shows the average TMRE fluores cence intensity from 10 randomly selected cells in each group and the mean TMRE fluorescence intensity at the end of the experimental period (85 min), indicating the signifi cant protective effects of serofendic acid. Fig. 2 . Effect of 5HD, a mitoKATPchannel blocker, on the protec tive effect of serofendic acid. The left coronary artery was occluded for 25 min with subsequent reperfusion. After 2 h of reperfusion, the hearts were sliced into coronal sections for TTC staining. Serofendic acid and diazoxide were each administered intravenously 15 min before ischemia and 5 min before reperfusion. 5HD was admin istered 5 min before the respective drugs. The numbers in the columns indicate the numbers of experiments performed. *P < 0.05 vs. vehicle treated group. Fig. 3 . Effect of serofendic acid and diazoxide on blood pressure. Arterial blood pressure was measured 15 min after the administration of drugs. *P < 0.05 vs. vehicletreated group.
Discussion
The major finding of this study is that serofendic acid reduced infarct size in a rat model of left coronary artery occlusion followed by reperfusion and that the protective effect was mediated by the opening of mitoKATP channels. This is the first report on the protection against myocardial ischemia-reperfusion injury.
We previously reported that serofendic acid protected cardiac myocytes against oxidative stress by preventing DYm loss, calcium overload, and ROS accumulation (27, 28) . The cardioprotective effect can be mediated by mito KATPchannel openers, and mitoKATPchannel blockers prevent both preconditioning and pharmacological cardio protection (34, 35) . MitoKATPchannel activation induces partial and modest mitochondrial membrane potential depolarization, thereby reducing the driving force for calcium uptake by mitochondria and preventing mitochondrial [Ca 2+ ] elevation (15) . In the present study, we showed that 5HD, a mitoKATPchannel blocker, abolished the protective effect of serofendic acid. This result suggests that the acti vation of mitoKATP channels plays a principal role in infarct size limitation of serofendic acid in vivo. However, we did not yet elucidate whether serofendic acid activates mitoKATP channels directly or indirectly. To reveal the target of serofendic acid in the activation of mitoKATP channels, we need further experiments. Serofendic acid possesses hydroxyl radical-scavenging activity (24) . It may partially contribute to myocardial protection because ROS is an important inducer of collapsing mitochondrial integrity followed by cell death. In fact, serofendic acid prevented ROS accumulation induced by H2O2 in neonatal rat cardiac myocytes (27) . Moreover, serofendic acid inhibited caspase3 activation and reduced TUNELpositive cells in cardiac myocytes and cortical neurons (26, 27) . Thus, serofendic acid may exert myocardial protection through the combina tion of these effects.
The opening of MPTP leads to DYm loss and cell death (9) . A growing body of evidence supports the concept that the inhibition of MPTP is an effective and promising strategy to prevent ischemia-reperfusion injury of the heart (5, 36, 37). One of the pharmacological targets to inhibit the opening of MPTP is an activation of mitoKATP channels. Opening of mitoKATP channels suppresses excessive eleva tion of mitochondrial [Ca 2+ ] and ROS, which are the most important inducers of MPTP opening (13, 15 -17) . MPTP opening leads to a sudden dissipation of DYm followed by mitochondrial dysfunction (17) . Serofendic acid decreased the number of cells undergoing DYm loss and also delayed the onset of DYm loss induced by ischemia-reperfusion in Langendorffperfused rat hearts. Our results suggest that serofendic acid attenuates myocardial ischemia-reperfusion injury by the prevention of MPTP opening mediated by the activation of mitoKATP channels.
Diazoxide causes hypotension because it acts not only on mitoKATP channels but also on membrane ATPsensitive potassium channels of vascular smooth muscle cells (31, 32, 38) . A highly selective agent for mitoKATP channels is preferred to avoid unwanted side effects. In fact, serofendic acid affected neither blood pressure nor individual death (data not shown). These results suggest that serofendic acid is free from unwanted side effects, in terms of the absence of the reduction of blood pressure and sudden death, which are among the major obstacles to clinical application. This result suggests that serofendic acid may selectively act on mitoKATP channels. Further experiments are essential to confirm whether serofendic acid acts on mitoKATP channels selectively.
In conclusion, our findings suggest that serofendic acid could be a novel candidate for cardioprotection against ischemia-reperfusion injury. As an endogenous substance, serofendic acid could be expected to have minimal, if any, unpredictable side effects. In fact, in the present study, we did not detect any effects of serofendic acid on blood pressure. This result further suggests that serofendic acid is free from unwanted side effects, which are among the major obstacles to clinical application. Therapeutic interventions designed to prevent MPTP opening during ischemia-reper fusion hold major promise as novel strategies for reducing cardiac injury from ischemia-reperfusion. Although further study should be performed in order to determine whether serofendic acid could improve the prognosis and left ventricular functions, serofendic acid or its analogs are potential therapeutic agents for cardiac ischemia-reperfusion injury.
